pathway

Tgf-Β

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Tgf-Β: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

946Connections
2Hypotheses
1Analyses
50Outgoing
50Incoming
0Experiments
5Debates

Summary

Tgf-Β is a biological pathway involved in neurodegeneration research. Key relationships include: activates, therapeutic target, inhibits. Associated with ALS, Aging, Als. Connected to 691 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🔀 Pathway Info
NameTgf-Β
Key Genes/ProteinsABCB1, ABCG2, ACSL4, ACSL5, ACVR2A, adamts4
Related Diseasesaging, Aging
Related PathwaysAkt

Pathway Diagram

graph TD
    Tgf__["Tgf-Beta"] -->|"interacts"| Circadian_Rhythm["Circadian Rhythm"]
    Tgf__["Tgf-Beta"] -->|"interacts"| Mapk["Mapk"]
    Tgf__["Tgf-Beta"] -->|"interacts"| Apoptosis["Apoptosis"]
    Tgf__["Tgf-Beta"] -->|"interacts"| Ferroptosis["Ferroptosis"]
    Tgf__["Tgf-Beta"] -->|"interacts"| Immune_Response["Immune Response"]
    Tgf__["Tgf-Beta"] -->|"interacts"| Innate_Immunity["Innate Immunity"]
    MIRO1["MIRO1"] -->|"associated"| Tgf__["Tgf-Beta"]
    APP["APP"] -->|"therapeutic target"| Tgf__["Tgf-Beta"]
    ST6GAL1["ST6GAL1"] -->|"regulates"| Tgf__["Tgf-Beta"]
    MAX["MAX"] -->|"regulates"| Tgf__["Tgf-Beta"]
    style Tgf__ fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (69)

TargetRelationTypeStr
MICROGLIAactivatescell_type0.90
Neuroinflammationsuppressesprocess0.80
Exosomesassociated_withentity0.80
Renal Fibrosiscausesdisease0.80
MMTassociated_withprocess0.80

Incoming (877)

SourceRelationTypeStr
Inflammationactivatesdisease1.00
Canceractivatesdisease1.00
Inflammationregulatesdisease1.00
TNFactivatesgene1.00
CANCERactivatesgene1.00

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
TGF-β1–SMAD2/3 Axis as Master Suppressor of Microglial Train 0.712 neuroinflammation What specific astrocyte-derived factors
TGF-β1-SMAD Signaling Dysregulation 0.380 neurodegeneration Which specific factors in conditioned me

Mentioning Analyses (1)

Scientific analyses that reference this entity

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (5)

Multi-agent debates referencing this entity

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: TREM2-Mediated Microglial Dysfunction Disrupts Perivascular T

closed · Rounds: 4 · Score: 0.50 · 2026-04-27

Hypothesis debate: TREM2-Dependent Microglial Senescence Transition

closed · Rounds: 4 · Score: 0.64 · 2026-04-26

Hypothesis debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegene

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the key mechanistic, therapeutic, and diagnostic dimensions of TREM2 in

closed · Rounds: 4 · Score: 0.92 · 2026-04-26

Related Research

Hypotheses and analyses mentioning Tgf-Β in their description or question text

No additional research found